CLINICAL_TRIALS
trial_result
· 2012-03-16
Clinical Trial Update: Primary UVB-311nm and Adalimumab in Psoriasis Patients [NA]
Summary
A completed clinical trial evaluating the combination of UVB 311 nm phototherapy and adalimumab in psoriasis patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical University of Graz | Conditions: Psoriasis | NA | Status: COMPLETED